循環器ジャーナル72巻2号

2024年04月発行

特集 心エコー　何をどこまで評価できるか？

Ⅱ. 心エコーを活かして心不全を治療する

心臓再同期療法の適応決定や設定最適化に心エコーの出番は？

著者： 中務智文¹ 石津智子¹

所属機関： ¹筑波大学医学医療系循環器内科

ページ範囲：P.240 - P.251

文献概要

POINT
・心エコー図におけるdyssynchrony評価はガイドライン上，限定的な言及にとどまる．
・CRTの自動調整機能は有用であるが，心エコー図の最適な設定と異なることがある．
・CRT導入後は血行動態が変化していくため，設定が適切かを定期的に評価し，調整する．

参考文献

1）Xiao HB, Lee CH, Gibson DG. Effect of left bundle branch block on diastolic function in dilated cardiomyopathy. Br Heart J 1991 ; 66 : 443-7.

2）日本循環器学会，日本心不全学会．2021年JCS/JHFSガイドラインフォーカスアップデート版　急性・慢性心不全診療．2021　https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Tsutsui.pdf

3）Chung ES, Leon AR, Tavazzi L, et al. Results of the predictors of response to CRT（PROSPECT）trial. Circulation 2008 ; 117 : 2608-16.

4）Ruschitzka F, Abraham WT, Singh JP, et al. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med 2013 ; 369 : 1395-405.

5）Beela AS, Ünlü S, Duchenne J, et al. Assessment of mechanical dyssynchrony can improve the prognostic value of guideline-based patient selection for cardiac resynchronization therapy. Eur Heart J Cardiovasc Imaging 2019 ; 20 : 66-74.

6）Curtis AB, Worley SJ, Adamson PB, et al. Biventricular pacing for atrioventricular block and systolic function. N Engl J Med 2013 ; 368 : 1585-93.

7）Pitzalis MV, Iacoviello M, Romito R, et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol 2002 ; 40 : 1615-22.

8）Dohi K, Suffoletto MS, Schwartzman D, et al. Utility of echocardiographic radial strain imaging to quantify left ventricular dyssynchrony and predict acute response to cardiac resynchronization therapy. Am J Cardiol. 2005 ; 96 : 112-6.

9）Seo Y, Ishizu T, Machino-Ohtsuka T, et al. Incremental Value of Speckle Tracking Echocardiography to Predict Cardiac Resynchronization Therapy（CRT）Responders. J Am Heart Assoc 2016 ; 5 : e003882.

10）Damy T, Ghio S, Rigby AS, et al. Interplay between right ventricular function and cardiac resynchronization therapy : an analysis of the CARE-HF trial（Cardiac Resynchronization-Hear Failure）. J Am Coll Cardiol 2013 ; 61 : 2153-60.

11）Sairaku A, Yoshida Y, Nakano Y, et al. Cardiac resynchronization therapy for patients with cardiac sarcoidosis. Europace. 2017 ; 19 : 824-30.

12）Sugano A, Seo Y, Yamamoto M, et al. Optimal cut-off value of reverse remodeling to predict long-term outcome after cardiac resynchronization therapy in patients with ischemic cardiomyopathy. J Cardiol 2017 ; 69 : 456-61.

13）Gold MR, Rickard J, Daubert JC, et al. Redefining the classification of response to cardiac resynchronization therapy : Results from the REVERSE Study. JACC Clin Electrophysiol 2021 ; 7 : 871-80.

14）Mullens W, Grimm RA, Verga T, et al. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol 2009 ; 53 : 765-73.

15）Seo Y, Ishizu T, Nakajima H, et al. Clinical utility of 3-dimensional echocardiography in the evaluation of tricuspid regurgitation caused by pacemaker leads. Circ J 2008 ; 72 : 1465-70.

16）Hayes DL, Boehmer JP, Day JD, et al. Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm 2011 ; 8 : 1469-75.

17）Gasparini M, Leclercq C, Lunati M, et al. Cardiac resynchronization therapy in patients with atrial fibrillation : the CERTIFY study（Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry）. JACC Heart Fail 2013 ; 1 : 500-7.

18）Bader H, Garrigue S, Lafitte S, et al. Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients. J Am Coll Cardiol 2004 ; 43 : 248-56.

19）Mullens W, Kepa J, De Vusser P, et al. Importance of adjunctive heart failure optimization immediately after implantation to improve long-term outcomes with cardiac resynchronization therapy. Am J Cardiol 2011 ; 108 : 409-15.

20）Lindenfeld J, Feldman AM, Saxon L, et al. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class Ⅳ heart failure, Circulation 2007 ; 115 : 204-12.